AEZS: Aeterna Zentaris Inc. Expected earnings per share growth for next year

Public company logo of zentaris.com (AEZS)

Aeterna Zentaris (AEZS) is developing licensing partnerships for oncology and orphan disease drugs. Consensus expectations for n+1 profit dynamics in the indicator chronology on the GURU.Markets chart demonstrate a market trend where 0.00 determines this parameter level. Aeterna Zentaris is implementing ESG standards to reduce waste and ensure bioethical control. The technological stack is further enhanced by robotic molecule screening and the automation of clinical data processing.

Aeterna Zentaris Inc (AEZS): Net earnings per share change forecast for next year from 07/04/2022 to 08/17/2024

Analytical breakdowns and data insights for company Zentaris (AEZS)

- share price and consensus valuation forecast:
Fundamental company valuation:AEZS, Aeterna Zentaris Inc
Finished products of Aeterna Zentaris Inc

This indicator aggregates current expert forecasts for net profit growth rates for the coming year, allowing for an assessment of market expectations regarding future business efficiency. For Aeterna Zentaris (AEZS) and its IP licensing model, the valuation of the EPS trend for the coming year reflects the potential for royalty growth coupled with low costs, determining the fundamental attractiveness of the shares.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|ETON: Expected earnings per share trend next year|Net earnings per share growth forecast for next year kamada.com (KMDA)|Expected earnings per share growth for next year Fulcrum Therapeutics FULC|Earnings growth forecast for next year ABEO (Abeona Therapeutics, Inc.)|Earnings growth forecast for next year Mereo BioPharma MREO|PLX - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PLRX|Applied Therapeutics (APLT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Rein Therapeutics Inc (RNTX)|Net earnings per share growth forecast for next year Gelteq Limited|AYTU (Aytu BioPharma) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Chemomab Therapeutics Ltd (CMMB)|SRXH (SRx Health Solutions) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Polyrizon Ltd PLRZ|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year